Drug Excretion in Breast Milk
NCT06056583
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
This is a prospective, non-randomized, phase I study design evaluating the in vivo activities and expression of OCT1 and BCRP in mammary gland of lactating women at three time points postpartum.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Postpartum
- Lactation
- Drugs in Breast Milk
- Mammary Drug Transporters
- BCRP
- OCT1
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 4
- Ages
- 14 days to 50 years
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- University of Washington
- Last updated on ClinicalTrials.gov
- August 6, 2024
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Washington · 1
- University of Washington · Seattle, WA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.